AETHOXYSKLEROL

This brand name is authorized in Austria, Finland, Japan, Lithuania, Malta, Netherlands, Poland, Turkey, United Kingdom

Active ingredients

The drug AETHOXYSKLEROL contains one active pharmaceutical ingredient (API):

1 Lauromacrogol 400 UNII 0AWH8BFG9A - POLIDOCANOL

Polidocanol has a concentration-dependent and volume-dependent damaging effect on the endothelium of blood vessels. Read about Polidocanol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AETHOXYSKLEROL Solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C05BB02	Polidocanol	C Cardiovascular system → C05 Vasoprotectives → C05B Antivaricose therapy → C05BB Sclerosing agents for local injection
Discover more medicines within C05BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 405647, 462069, 462093
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 115018, 115022, 115026, 115030, 115034
Country: JP	医薬品医療機器総合機構	Identifier(s): 3329405A1022
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1091315, 1091317, 1091318, 1091319
Country: MT	Medicines Authority	Identifier(s): AA565/36201, AA729/28101
Country: NL	Z-Index G-Standaard	Identifier(s): 14274655, 14274663, 14274671, 14274701
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 2143, 3719, 3727, 3735
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100107315, 100107321, 100107338, 100169380, 100192723
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699699771050, 8699708751745, 8699708751752, 8699708751769, 8699708751776, 8699708751783